FORMULATION AND PHARMACOKINETIC EVALUATION OF RITONAVIR FLOATING TABLETS IN THE MANAGEMENT OF AIDS
Abstract
In the current study, gastro-retentive tablets of Ritonavir was developed to increase its oral bioavailability using hydrophilic polymers HPMC K 4M, K 15M, and K 100M as release retarding agents. Polyox WSR 303 was chosen as resin, sodium bicarbonate was used as effervescent agents. The tablets were prepared by direct compression method and FTIR studies revealed that there is no interaction between the drug and polymers used for the formulation. Among all the formulations F21 containing HPMC K 100M, Crospovidone, Polyox WSR 303 and sodium bicarbonate, as gas generating agent was choosen as optimized formulation based on the evaluation parameters, floating lag time (33 sec) and total floating time (>24 h) and in vitro dissolution studies. From in vitro dissolution studies, the optimized formulation F21 and marketed product was shown 98.67% and 95.09 ± 5.01% of drug release respectively. From in vivo bioavailability studies, after oral administration of floating tablet containing 100 mg Ritonavir, the Cmax, Tmax, and AUC0–∞ of optimized gastroretentive formulation were found to be 30.11 ± 1.16µg/mL, 8.00±1.23 h and 173 ± 26.34µg*h/ml, respectively. Cmax and AUC values of optimized formulation were found to be significantly higher than of marketed product, where longer gastric residence time is an important condition for prolonged or controlled drug release and also for improved bioavailability.
Keywords:
Ritonavir AIDS, Floating tablets, Polyox, In vivo bioavailability studiesDOI
https://doi.org/10.25004/IJPSDR.2018.100610References
2. Emara LH, Abdou AR, El-ashmawy AA, Mursi NM. Preparation and Evaluation of metronidazole sustained release floating tablets. Int J Pharm Pharm Sci. 2014; 6(9):198-204.
3. Mojaverian PH, Vlasses PE, Kellner, Rocci M. Effects of gender posture and age on gastric residence time of an indigestible solid pharmaceutical consideration. Pharm Res. 1988; 10: 639–644.
4. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled release drug delivery system for prolonged gastric residence: an overview. Drug Dev Ind Pharm. 1996; 22(6): 531- 539.
5. Sawant K, Patel M, Patel J, Mundada P. Formulation, optimization, characterization and in vivo anti-ulcer activity of esomeprazole magnesium trihydrate Gastro-resistant microspheres. Int J Pharm Pharm Sci. 2014; 6(9):198-204.
6. Hwang SK, Park H, Park K. Gastric retentive drug delivery systems. Crit Rev Ther Drug Carrier Syst. 1998; 15: 243–284.
7. Gruber P, Rubinstein A, Li VH, Bass P, Robinson JR. Gastric emptying of non-digestible solids in the fasted dog. J Pharm Sci. 1987; 76(2): 117-122.
8. Desai S, Bolton S. A Floating Controlled Release Drug Delivery System. In vitro–In vivo evaluation. Pharma Res. 1993; 10(9): 1321-325.
9. Li S, Lin S, Daggy BP, Mirchandani HL, Chien TW. Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev Ind Pharm. 2002; 28:783-793.
10. Martindale. The Complete Drug Reference, 35th Edition. 766-779.
11. Rama Rao T, Bala Krishna K, Asif Hussain M, Anjum M, Azizurrahman M. Formulation and Evaluation of Gastroretentive Floating Tablets of Quetiapine Fumarate. Res J Pharm Biol Chem Sci. 2014; 5 (5): 8575-8585.
12. Nasrin N, Asaduzzaman M, Rumana M, Rizwan F, Alam A. A Comparative Study of Physical Parameters of Selected Ketorolac tromethamine tablets available in the Pharma Market of Bangladesh. J Appl Pharm Sci. 2008; 01 (08): 101-103.
13. Penners G, Lustig K, Jorg PVG. Expandable pharmaceutical forms, US patent 5 1997; 651-985.
14. Phuapradit W, Bolton S. Influence of tablet density on oral absorption of sustained release acetaminophen matrix tablets. Drug Dev Ind Pharm. 1991; 17:1097-1107.
15. Phuapradit W. Influence of Tablet Buoyancy on Oral Absorption of Sustained Release Acetaminophen Matrix Tablets. Jamaica, NY: St John's University; 1989.
16. Tyagi LK, Kori ML. Stability Study and In-vivo Evaluation of Lornoxicam Loaded Ethyl Cellulose Microspheres. Int J Pharm Sci Drug Res. 2014; 6(1): 26-30.
17. Sasa B, Julijana K, Franc V, Polona V, Zorko B. Optimization of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm.2000; 195:125–135.
Published
Abstract Display: 652 
PDF Downloads: 743 
